The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib
Conference paper > Summary Text
Authors: M.K. Vasakova, Nesrin MOĞULKOÇ BISHOP, M. Kramer, M. Doubková, M. Placková, V. Müller, M.J. Studnicka, M. Zurkova, L. Lacina, K. Lewandowska, V. Bartos, P. Ovesna, J. Gregor
B17. EMERGING DATA ON DISEASE AND SYMPTOM BASED THERAPEUTICS FOR PATIENTS WITH IPF, , , International, Summary Text, pp A2779-A2779
DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2779